Literature DB >> 26841069

Potential Role of Axonal Chemorepellent Slit2 in Modulating Adventitial Inflammation in a Rat Carotid Artery Balloon Injury Model.

Dong Liu1, Yan Xiao, Romesh R Subramanian, Ei-Ichi Okamoto, Josiah N Wilcox, Leonard Anderson, Hector De Leon.   

Abstract

Leukocyte infiltration of adventitial and perivascular tissues is an early event in the development of vascular remodeling after injury. We investigated whether Slit/Robo-an axonal chemorepellent system in vertebrate and invertebrate development-is activated during the inflammatory phase that follows endothelial denudation. Using the rat carotid artery model of angioplasty, we conducted a time course analysis of mRNAs encoding Slit ligands (Slit2 and Slit3) and Robo receptors (Robo1, Robo2, and Robo4), as well as proinflammatory cell adhesion molecule (CAM) genes. Adventitial inflammatory cells were counted in immunostained arterial sections. E-selectin, vascular CAM-1, and intercellular CAM-1 were upregulated 2-3 hours after injury, followed by infiltration of neutrophils and monocytes as evidenced by real-time polymerase chain reaction, in situ hybridization, and immunohistochemistry. Slit2, Slit3, and Robo genes exhibited no expression changes at 3 hours; however, they were markedly upregulated 1 day after angioplasty. Intercellular CAM-1 expression was reduced by 50%, and the number of adventitial neutrophils decreased by >75% 1 day after angioplasty. Slit2 has been shown to be a potent chemorepelent of leukocytes, endothelial cells, and smooth muscle cells. Thus, we decided to further investigate the localization of Slit2 in injured vessels. Immunohistochemical stainings revealed the presence of Slit2 within the vessel wall and in the perivascular vasa vasorum of naive and injured arteries. Double immunohistochemical analyses showed that infiltrating monocytes expressed Slit2 in the perivascular and adventitial tissues of injured arteries 1 and 3 days postangioplasty. In addition, recombinant full-length Slit2 and Slit2-N/1118, an N-terminal fragment of Slit2, inhibited stromal cell-derived factor 1-mediated migration of circulating rat peripheral blood mononuclear cells. In summary, adventitial activation of CAM genes and neutrophil infiltration preceded upregulation of Slit/Robo genes. Sli2 expression colocalized with infiltrating inflammatory cells in the adventitial layer. This temporospatial association suggests that leukocyte chemorepellent Slit2 may be involved in halting the adventitial accumulation of inflammatory cells in injured vessels.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26841069      PMCID: PMC4861666          DOI: 10.1097/FJC.0000000000000369

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  40 in total

1.  The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors.

Authors:  J Y Wu; L Feng; H T Park; N Havlioglu; L Wen; H Tang; K B Bacon; Y Rao
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  The N-terminal leucine-rich regions in Slit are sufficient to repel olfactory bulb axons and subventricular zone neurons.

Authors:  J H Chen ; L Wen; S Dupuis; J Y Wu; Y Rao
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

3.  Role of alpha5beta1 and alphavbeta3 integrins on smooth muscle cell spreading and migration in fibrin gels.

Authors:  Y Ikari; K O Yee; S M Schwartz
Journal:  Thromb Haemost       Date:  2000-10       Impact factor: 5.249

4.  Perivascular inflammation after balloon angioplasty of porcine coronary arteries.

Authors:  E Okamoto; T Couse; H De Leon; J Vinten-Johansen; R B Goodman; N A Scott; J N Wilcox
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

5.  Differential cell cycle progression patterns of infiltrating leukocytes and resident cells after balloon injury of the rat carotid artery.

Authors:  C Hay; C Micko; M F Prescott; G Liau; K Robinson; H De Leon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

6.  Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery.

Authors:  H De Leon; J D Ollerenshaw; K K Griendling; J N Wilcox
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

7.  Repellent signaling by Slit requires the leucine-rich repeats.

Authors:  R Battye; A Stevens; R L Perry; J R Jacobs
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

8.  Diversity and specificity of actions of Slit2 proteolytic fragments in axon guidance.

Authors:  K T Nguyen Ba-Charvet; K Brose; L Ma; K H Wang; V Marillat; C Sotelo; M Tessier-Lavigne; A Chédotal
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

9.  Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils.

Authors:  M Roque; J T Fallon; J J Badimon; W X Zhang; M B Taubman; E D Reis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

10.  Slit inhibition of retinal axon growth and its role in retinal axon pathfinding and innervation patterns in the diencephalon.

Authors:  T Ringstedt; J E Braisted; K Brose; T Kidd; C Goodman; M Tessier-Lavigne; D D O'Leary
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

View more
  3 in total

1.  Different Isoforms of the Neuronal Guidance Molecule Slit2 Directly Cause Chemoattraction or Chemorepulsion of Human Neutrophils.

Authors:  Darrell Pilling; Luis E Chinea; Kristen M Consalvo; Richard H Gomer
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

Review 2.  Neuronal guidance proteins in cardiovascular inflammation.

Authors:  Marius Keller; Valbona Mirakaj; Michael Koeppen; Peter Rosenberger
Journal:  Basic Res Cardiol       Date:  2021-01-29       Impact factor: 17.165

Review 3.  Guidance Molecules in Vascular Smooth Muscle.

Authors:  Alexandra Christine Finney; Anthony Wayne Orr
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.